$HIPH- News just out! #CBD, Sales of $169,313 for 4th

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
993
$HIPH- News just out! #CBD, Sales of $169,313 for 4th quarter!!! $HIPH beat its projected revenue/ sales expectations . Newly acquired GENTS subsidiary proving to be a good acquisition on behalf of New CEO Ryan Fishoff. $HIPH also to work on a #CBD infused skin cream for GENTS subsidiary. $HIPH already has the only hydrogen infused #CBD energy drink. Plan to up list by end of 2018.

See today's just out PR/ News below and Globalnewswire

American Premium Water Corp. (OTC:HIPH) Announces Subsidiary Gents Q4 Revenue of $169,313
GlobeNewswire•April 3, 2018

PLAYA VISTA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that its Gents subsidiary posted revenue of $169,313 in the fourth quarter of 2017, exceeding the 600-700% guidance provided last week, with a 150,000% increase in revenues over the same period last year (Q4 17’-Q4 16’). The Gents results will propel the Company to over a 400% year over year increase in top-line revenue. The 2017 year-end report will be released later this week.

Ryan Fishoff, CEO American Premium Water Corporation commented: “I am happy to report to our shareholders that Gents financial performance in Q4 beat even internal expectations. I was a bit conservative with guidance last week, but even I am blown away with the results. We had a good holiday selling season; same store sales were up compared to last year for our department store partners. We have seen progress from a number of initiatives we began in Q1 and I am optimistic that the momentum will continue through 2018. We will be releasing full year end results for the Company by end of the week and I am confident, with the addition of Gents, the Company guidance increases to roughly 400% year over year revenue growth from 2017.”

“The Gents acquisition has already been successful for the Company. In addition to the revenue it has brought in, the Gents team has brought expertise in marketing and branding, as well as logistical & distribution support that will be utilized going forward as we ramp up the sales and distribution of LALPINA beverages. The intellectual capital acquired from Gents will be critical to for the Company to achieve its goals in the near and long term,” added Mr. Fishoff

Gents (www.gentsco.com) is sold in over 200 luxury retail outlets, including Bloomingdales, Saks Fifth Avenue, and Nordstroms. The brand, founded in 2012, focuses on men’s accessories, and has created a niche as being the first brand to focus on luxury baseball caps. The brand recently announced a joint venture with Zhangjiagang Advanced Company, a Chinese company that will begin distributing Gents products into mainland China. In addition to expanding geographically, Gents is looking to add product categories in 2018, leveraging its distribution network for accretive revenue.

“Gents provides tremendous growth potential for the Company. It’s a great brand that has broad appeal. The Company is in a position to invest in the brand, and diversifying the product offerings is a key part of this strategy. There are 35 registered trademarks for Gents. I want to start leveraging them. Apparel is one area that we are going to aggressively pursue. Men’s grooming is another that I see lots of potential for. I’ve also had exploratory discussions with CBD producers about incorporating CBD into topical skin creams. From my research in the market, I have not seen any products like this in the men’s luxury marketplace, and this could be a real niche category for us. These are all things to consider as we evaluate how to invest the capital we are raising from the Reg A (Regulation 1/A) we recently submitted for review,” Mr. Fishoff commented.

The Company submitted a 1/A filing to the Securities and Exchange Commission for review on March 26th. The Company is awaiting feedback and comments before the offering is effective, which at that point will determine the offering price and number of shares to be issued. The Company feels this structure will allow it to raise non-toxic capital and giving it the means to start the uplist process, which is a goal of the Company’s to be completed by the end of 2018.

American Premium Water Corp is the publicly holding trading company that owns LALPINA HYDROGEN, LALPINA HYDROGEN CBD & Gents.

Please follow us on our social media outlets listed below:

@americanpremium
@lalpinabrands
@GentsCo
#Gentsco
#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s, Nordstrom, and Saks Fifth Avenue.

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo

Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors by Alfred Culbreth, Founder /Director.

Disclaimer Regarding Forward Looking Statements

Certain statements in this press release, on American Premium Water Corporation’s (“APWC”) website and other oral and written statements made by APWC from time to time are “forward-looking statements”, as that term is defined in Section 27A of the United States Securities and Exchange Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, Forward-looking statements include, without limitation, statements regarding beliefs, objectives, intentions, goals, plans, strategies, financial projections, any other statements regarding the future and any statements that are not purely historical. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and APWC expressly disclaims any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date thereof. All forward-looking statements, whether written or oral and whether made by or on behalf of the APWC, are expressly qualified by these cautionary statements. Forward-looking statements involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. APWC’s expectations, beliefs and projections are expressed in good faith and are believed by the APWC to have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. A variety of factors, many of which are beyond APWC’s control affect APWC’s operations, performance, business strategy and results and could cause the actual results, performance or achievements of APWC to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For APWC, particular uncertainties arise, amongst others but not limited to and not in any order of importance, from (i) focusing on and allocating more resources on certain target markets (ii) the possibility to raise further equity and debt to fund future growth, (iii) changes in demand for APWC’s products, (iv) performance issues with key suppliers, affiliates, agents, advisors or subcontractors, (v) changes in government changes in laws or regulations to which APWC or its suppliers are subject, including environmental laws and regulations relating to water or water sources and (vi) the inability to complete announced acquisitions, difficulty or unanticipated expenses in connection with integrating acquired businesses and the risk that anticipated synergies and opportunities as a result of acquisitions will not be realized or the risk that acquisitions do not perform as planned, including, for example, the risk that acquired businesses will not achieve revenue projections.

THIS NEWS RELEASE HAS BEEN PREPARED BY APWC’S MANAGEMENT, WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

Contact Information:

American Premium Water Corporation
12777 Jefferson Blvd.
Suite 300
Playa Vista, CA 90066-7408
(888)-983-0054

Stock Symbol: HIPH
General Inquiries: info@americanpremiumwater.com
Investor Relations: ir@americanpremiumwater.com
Company Website: http://www.lalpinahydrogen.com/investor-page.html
Twitter: @americanpremium, @lalpinawater
Instagram: #lalpinahydrogen

Contact:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading